Company / Total Assets
KIORA PHARMACEUTICALS INC Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$24.3M
FY2025
5-year range
$10.1M / $36.5M
FY2021-FY2025
Trend
-33.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 8 years, ranging from $10M in FY2016 to $36M in FY2024.
Based on SEC 10-K filings.
$24M in FY2025 with a 5-year CAGR of +9.9%.
Improved from $15M to $24M over the past 4 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +9.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +9.9%, indicating consistent growth.
- In FY2025, total assets decreased 33.5% year-over-year.
- Peak total assets was recorded in FY2024.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.3M | -33.5% |
| FY2024 | $36.5M | +140.7% |
| FY2021 | $15.2M | +0.0% |
| FY2020 | $15.2M | +49.9% |
| FY2019 | $10.1M | -29.2% |
| FY2018 | $14.3M | -0.2% |
| FY2017 | $14.3M | +47.0% |
| FY2016 | $9.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026